Get in Touch

Let's talk.

We're open to investor inquiries, clinical and manufacturing partnerships, and serious technical conversations about the platform.

Direct Contact

Reach Martin directly.

martin@dianovohealth.comFollow us on LinkedIn

Martin Lundberg
CEO & Co-Founder, Dianovo AB
Skomakaregatan 17 B · 223 50 Lund · Sweden

Pilot interest

Clinical, public-health, and NGO teams interested in deploying CENTiV in pilot settings.

Partner with us

Manufacturing, clinical validation, distribution, and technical partners.

Investor inquiries

Tell us about your fund and the stages you typically invest at. We'll send a current deck and set up an introductory call.

We aim to respond within 2 business days.

CENTiV™ is currently in development. Specifications, performance targets, and system features described on this website reflect design objectives and are subject to ongoing validation and regulatory review.